Why the study?
Does a five-protein score improve stroke risk prediction beyond the CHA₂DS₂-VASc score in patients with atrial fibrillation?
Population
709 participants with atrial fibrillation from the UK Biobank Pharma Proteomics Project, including 76 with…
Comparison
A five-protein score added to the CHA₂DS₂-VASc… vs CHA₂DS₂-VASc score alone
Design
Cohort
Key result
Adding a five-protein score to the CHA₂DS₂-VASc score improved discrimination for post-AF stroke risk, increasing the concordance index from 0.681 to 0.768.
Authors
Loading...
Hypothesis-generating for biomarker-enhanced AF stroke risk prediction; leaves open prospective validation before practice change.
Cohort (n=709)
Does a five-protein score improve stroke risk prediction beyond the CHA₂DS₂-VASc score in patients with atrial fibrillation?
Effect estimate: NRI 0.459
p-value: p=0.028
A novel five-protein score provides incremental predictive value beyond the CHA₂DS₂-VASc score for assessing stroke risk in patients with atrial fibrillation.
Huang et al. (2026) conducted a cohort in atrial fibrillation (n=709). Five-protein score vs. CHA₂DS₂-VASc score was evaluated on incident stroke (NRI 0.459, p=0.028). Adding a five-protein score to the CHA₂DS₂-VASc score improved discrimination for post-AF stroke risk, increasing the concordance index from 0.681 to 0.768.